Wholesale China Crema Ceramide Manufacturers Pricelist - PromaCare-TA / Tranexamic Acid – Uniproma

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our enterprise since its inception, usually regards product top quality as business life, repeatedly enhance manufacturing technology, make improvements to product excellent and continuously strengthen enterprise total high quality administration, in strict accordance with all the national standard ISO 9001:2000 for Organic Uv Filters , Surfer Sunscreen , Thick Sunscreen , Our concept would be to assist presenting the confidence of each prospective buyers while using the offering of our most honest service, as well as right merchandise.
Wholesale China Crema Ceramide Manufacturers Pricelist - PromaCare-TA / Tranexamic Acid – Uniproma Detail:

Product Paramete

Trade name PromaCare-TA
CAS 1197-18-8
Product Name Tranexamic Acid
Chemical Structure
Application Medicine
Package 25kgs net per drum
Appearance White or almost white, crystalline power
Assay 99.0-101.0%
Solubility Water soluble
Shelf life 4 years
Storage Keep container tightly closed and in a cool place. Keep away from heat.

Application

Tranexamic Acid, also known as clotting acid, is an antifibrinolytic amino acid, which is one of the commonly used anticoagulants in clinic

This product can be used for:

1. Trauma or surgical bleeding of prostate, urethra, lung, brain, uterus, adrenal gland, thyroid, liver and other organs rich in plasminogen activator.

2. They are used as thrombolytic agents, such as tissue plasminogen activator (t-PA), streptokinase and urokinase antagonist.

3. Induced abortion, placental exfoliation, stillbirth and amniotic fluid embolism caused by fibrinolytic bleeding.

4. Menorrhagia, anterior chamber hemorrhage and severe epistaxis with increased local fibrinolysis.

5. It is used to prevent or reduce bleeding after tooth extraction or oral surgery in hemophilic patients with factor VIII or factor IX deficiency.

6. This product is superior to other antifibrinolytic drugs in hemostasis of mild hemorrhage caused by rupture of central aneurysm, such as subarachnoid hemorrhage and intracranial aneurysm hemorrhage. However, attention must be paid to the risk of cerebral edema or cerebral infarction. As for severe patients with surgical indications, this product can only be used as an adjuvant.

7. For the treatment of hereditary vascular edema, can reduce the number of attacks and severity.

8. Patients with hemophilia have active bleeding.

9. It has definite curative effect on chloasma.


Product detail pictures:

Wholesale China Crema Ceramide Manufacturers Pricelist - PromaCare-TA / Tranexamic Acid  – Uniproma detail pictures


Related Product Guide:

Responsible excellent and fantastic credit rating standing are our principles, which will help us at a top-ranking position. Adhering towards the tenet of "quality initial, buyer supreme" for Wholesale China Crema Ceramide Manufacturers Pricelist - PromaCare-TA / Tranexamic Acid – Uniproma, The product will supply to all over the world, such as: Lesotho, Yemen, Argentina, We've got constructed strong and long co-operation relationship with an enormous quantity of companies within this business overseas. Immediate and specialist after-sale service supplied by our consultant group has happy our buyers. In depth Info and parameters from the merchandise will probably be sent to you for any thorough acknowledge. Free samples may be delivered and company check out to our corporation. n Portugal for negotiation is constantly welcome. Hope to get inquiries type you and construct a long-term co-operation partnership.
  • We have been cooperated with this company for many years, the company always ensure timely delivery ,good quality and correct number, we are good partners.
    5 Stars By Page from Jordan - 2017.06.25 12:48
    The factory has advanced equipment, experienced staffs and good management level, so product quality had assurance, this cooperation is very relaxed and happy!
    5 Stars By Maggie from Azerbaijan - 2017.08.28 16:02